- Home
- ROC vs COYA Comparison
ROC vs COYA Comparison
Compare ROC & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROC | COYA |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | United States |
| Employees | 82 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.8M | 97.8M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | ROC | COYA |
|---|---|---|
| Price | $5.01 | $4.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $9.00 | ★ $15.80 |
| AVG Volume (30 Days) | 32.2K | ★ 148.2K |
| Earning Date | 03-31-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,945,753.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $763.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 123.57 |
| 52 Week Low | $4.41 | $3.71 |
| 52 Week High | $7.80 | $7.75 |
Technical Indicators
Market Signals| Indicator | ROC | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 37.50 | 53.50 |
| Support Level | N/A | $4.50 |
| Resistance Level | $6.50 | $5.18 |
| Average True Range (ATR) | 0.45 | 0.36 |
| MACD | -0.09 | 0.03 |
| Stochastic Oscillator | 32.28 | 53.58 |
Price Performance
Historical ComparisonAbout ROC Rank One Computing Corporation Common stock
Rank One Computing Corp is an American artificial intelligence company. It develops AI systems that analyze visual data to identify and interpret objects and activities. The company's focus is on biometric identity, digital forensics, and real-time video analytics. It uses the term 'Vision AI,' which is an operational AI built for accuracy, speed, and auditability. The company generates revenue from the sale of access to its software platforms, maintenance services, and professional services.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.